Literature DB >> 1299471

The SmithKline Beecham 'quality of life' scale: a validation and reliability study in patients with affective disorder.

M J Stoker1, G C Dunbar, G Beaumont.   

Abstract

The rationale for the development of Repertory-Grid based quality of life assessment (QOL) is described. The emergent scale, the SmithKline Beecham Quality of Life Scale (SBQOL) utilizes 23 predetermined constructs and three fixed elements: self now, ideal self and sick self. Inclusion of the latter two elements provides a personal frame of reference for the individual and recognizes the highly idiosyncratic and subjective nature of the experience which constitutes quality of life. A study of the validity and reliability of the SBQOL was conducted in 129 patients presenting to their GP with either major depression or generalized anxiety disorder, as defined by DSM III R. Patients were treated at the discretion of their GP and followed over a period of 12 weeks with assessments of treatment efficacy being performed at 6 weeks and 12 weeks in parallel with administration of the SBQOL. The results from co-administration of standard efficacy measures such as the Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Scale (HAMA) with the SBQOL, provided good evidence of construct validity. Evidence in support of the concurrent validity of the SBQOL was provided by co-administration of the Sickness Impact Profile and General Health Questionnaire (external criteria) with the SBQOL scale. Test-retest reliability and internal consistency were high. No obvious advantage was conferred by the use of principal components analysis from the Flexigrid software package in contrast to a simple arithmetical procedure for computing interelement distances. It is concluded that the SBQOL provides a valid, reliable and practicable approach to the assessment of quality of life in patients with affective disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1299471     DOI: 10.1007/bf00704433

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  8 in total

1.  The sickness impact profile. Development of an outcome measure of health care.

Authors:  B S Gilson; J S Gilson; M Bergner; R A Bobbit; S Kressel; W E Pollard; M Vesselago
Journal:  Am J Public Health       Date:  1975-12       Impact factor: 9.308

Review 2.  Measurement of psychological distress and well-being.

Authors:  P Bech
Journal:  Psychother Psychosom       Date:  1990       Impact factor: 17.659

3.  Quality of life assessment in clinical trials: methodologic issues.

Authors:  N K Aaronson
Journal:  Control Clin Trials       Date:  1989-12

4.  Measuring overall health: an evaluation of three important approaches.

Authors:  J L Read; R J Quinn; M A Hoefer
Journal:  J Chronic Dis       Date:  1987

5.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

6.  Investigation of the Karnofsky Performance Status as a measure of quality of life.

Authors:  A Grieco; C J Long
Journal:  Health Psychol       Date:  1984       Impact factor: 4.267

7.  The Sickness Impact Profile: development and final revision of a health status measure.

Authors:  M Bergner; R A Bobbitt; W B Carter; B S Gilson
Journal:  Med Care       Date:  1981-08       Impact factor: 2.983

8.  Can the Sickness Impact Profile measure change? An example of scale assessment.

Authors:  C R MacKenzie; M E Charlson; D DiGioia; K Kelley
Journal:  J Chronic Dis       Date:  1986
  8 in total
  6 in total

Review 1.  Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.

Authors:  Dennis A Revicki; Louis S Matza; Emuella Flood; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial.

Authors:  P Hopwood; R J Stephens; D Machin
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

Review 3.  Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective.

Authors:  P Bech
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 4.  Measuring quality of life in patients with depression or anxiety.

Authors:  D Whalley; S P McKenna
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

Review 5.  Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.

Authors:  J Grimley Evans; R Malouf; F Huppert; J K van Niekerk
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Patient-Proxy Agreement Regarding Health-Related Quality of Life in Survivors with Lymphoma: A Propensity-Score Matching Analysis.

Authors:  Richard Huan Xu; Dong Dong
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.